Specialty Infusion / Healthcare AI Governance
AI Agent Governance for Specialty Infusion Providers
AI agent governance for specialty infusion providers means applying runtime identity verification, least-privilege permissions, policy enforcement, and auditable logging to AI agents that interact with EHR, pharmacy, and payer systems, so agent actions touching protected health information or billing data remain controlled and reviewable under HIPAA's existing technical safeguards.
Where AI agents are entering infusion workflows
Specialty infusion operations involve several handoffs between clinical, pharmacy, and payer systems. AI agents are increasingly positioned at each of these handoffs, which is why governance needs to account for the full span of touchpoints rather than a single integration.
Patient Intake
Agents collecting and structuring referral and eligibility data before scheduling.
Prior Authorization
Agents drafting or submitting authorization requests through payer-facing interfaces.
Scheduling Coordination
Agents reconciling infusion chair availability with pharmacy and nursing resources.
Care Coordination
Agents relaying updates between clinical, pharmacy, and billing systems during treatment cycles.
Operational realities that shape agent governance in infusion workflows
Before setting policy, it helps to understand the conditions that make infusion workflows distinct from a typical back-office automation use case.
- 1
Multi-system orchestration
Agents often chain multiple tool calls across EHR, pharmacy, and payer platforms within a single task, increasing the number of access points requiring control.
- 2
Mixed sensitivity of data
A single workflow may combine clinical data, billing codes, and insurance eligibility information, each with different access and disclosure implications.
- 3
Payer interface variability
Prior authorization and claims interactions differ by payer, and CMS's Interoperability and Prior Authorization Final Rule (CMS-0057-F) will introduce FHIR-based APIs for electronic prior authorization with compliance phased through 2026 and 2027.
- 4
Consequential actions
Agent-driven actions such as submitting a prior authorization or modifying a billing code can affect patient care timing and reimbursement accuracy if executed incorrectly.
- 5
Core components of runtime agent governance
Implementation priorities before scaling agent deployment
Teams preparing to expand agent use across EHR, pharmacy, and payer systems should work through the following items first.
- Map existing EHR, pharmacy, and payer integration points to identify where agents will read data or perform write actions.
- Assign distinct agent identities rather than shared service accounts to enable per-action attribution.
- Scope credentials per tool and system instead of granting broad standing access across all integrations.
- Define human-in-the-loop approval gates for high-consequence actions such as prior authorization submission or billing modifications.
- Confirm business associate agreement coverage for any third-party agent platform or underlying model processing ePHI.
- Establish recurring access review cycles for agent scopes and credentials as workflows and integrations change.
Audit logging and HIPAA accountability
Common questions from governance leaders
Does HIPAA treat AI agent actions differently from human actions on ePHI?
No direct HHS guidance specifically addresses AI agents, but the Security Rule's technical safeguards apply regardless of whether the actor is human or automated, since the rule governs systems that create, receive, maintain, or transmit ePHI.
What does least privilege mean for an AI agent interacting with multiple systems?
It means scoping the agent's credentials to only the specific tools, data fields, and actions required for its assigned task in each system, rather than granting broad or standing access across EHR, pharmacy, and payer platforms.
How does the Model Context Protocol relate to agent governance?
MCP defines a client-server architecture for connecting agents to external tools and data, incorporating an OAuth 2.1-based authorization framework that supports mediated, scoped connections instead of static embedded credentials.
Will CMS's prior authorization rule affect how agents interact with payers?
CMS-0057-F requires impacted payers to implement FHIR-based APIs for electronic prior authorization, phased in through 2026 and 2027. This creates a defined technical interface that agent-driven prior authorization workflows will need to operate through, though the rule does not address AI agents directly.
Evaluate runtime governance before scaling agent deployment
Trussed AI provides runtime governance for enterprise AI agents, including agent identity, least-privilege permissions, tool approval workflows, and audit logging for agents operating across sensitive healthcare systems.
Request a Demo